You are here: Industry Insights > CDMO

News List

KD Pharma Acquires Rohner AG Manufacturing Assets contractpharma
March 30, 2021
The KD Pharma Group has acquired the manufacturing assets of the former Rohner AG. The assets give KD Pharma access to new complementary technologies that will allow the company to further expand its pharmaceutical CDMO business.
Chime Biologics Expands CDMO Capabilities contractpharma
March 30, 2021
Chime Biologics, a China-based CDMO, has secured a total commitment of $190 million investment from institutional investors.
mAbxience Expands Biosimilar and CDMO Manufacturing Capacity contractpharma
March 26, 2021
ABEC, a global provider of integrated solutions and services for biopharmaceutical manufacturing, said that mAbxience will equip their state-of-the-art cGMP facility in León, Spain with an ABEC 4,000L Custom Single Run (CSR) Bioreactor.
Chime Biologics announces Marc Funk as new Board Director prnasia
March 22, 2021
Chime Biologics is pleased to announce the appointment of Marc Funk to its Board of Directors. Marc brings more than 20 years of leadership and industry experience in the global CDMO space.
Alcami Names Patrick D. Walsh as Chairman and CEO contractpharma
March 22, 2021
Alcami, a global pharmaceutical CDMO, has appointed Patrick D. Walsh as chairman and chief executive officer, effective immediately. He succeeds Walter J. Kaczmarek III, who is stepping down as chief executive.
Fujifilm Selects North Carolina for $2B Bio CDMO Facility contractpharma
March 22, 2021
Fujifilm Corporation said it has selected Holly Springs, NC as the location for its new large-scale cell culture production site in the U.S.
ANI Pharmaceuticals Strengthens CDMO Biz contractpharma
March 12, 2021
ANI Pharmaceuticals has struck a $163.5 million deal to acquire Novitium Pharma, a privately held, New Jersey-based pharmaceutical company with development, manufacturing, and commercialization capabilities.
Altasciences Doubles Size of PA CDMO Facility contractpharma
March 11, 2021
The additional 35,000-sq.-ft. building in Philadelphia will include warehouse and cGMP manufacturing suites.
Charles River Acquires CDMO Cognate BioServices contractpharma
February 18, 2021
Charles River Laboratories has signed an agreement to acquire Cognate BioServices, a cell and gene therapy contract development and manufacturing organization (CDMO), for approximately $875 million.
Wacker Strengthens Biologics Business contractpharma
February 05, 2021
The Munich, Gemany-based chemical company Wacker is acquiring 100 percent of the shares in pharmaceutical contract manufacturer Genopis from South Korea-based firms Helixmith and Medivate Partners.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 29 30 Next page